MedTrace Logo

Observational Study on Treatment Satisfaction of Levemir® Versus Protaphane® During "Real-life" Usage in Germany

NCT00665808 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8125

Last updated 2016-10-28

No results posted yet for this study

Summary

This NON INTERVENTIONAL OBSERVATIONAL STUDY is conducted in Europe. The purpose of this NON INTERVENTIONAL OBSERVATIONAL STUDY is to primarily investigate treatment satisfaction when using Levemir® versus Protaphane® in combination with OADs in daily settings.

Conditions

Interventions

DRUG

insulin detemir

Observational study on treatment satisfaction of Levemir ® versus Protaphane® during "real-life" usage in Germany

DRUG

isophane human insulin

Observational study on treatment satisfaction of Levemir ® versus Protaphane® during "real-life" usage in Germany

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00665808 on ClinicalTrials.gov